Although not significant, sGFAP also showed a trend towards higher baseline values in relapse patients.
← all excerpts
Relapse or no relapse in multiple sclerosis: Can disease activity biomarkers support the clinician?
1
—
—
Although not significant, sGFAP also showed a trend towards higher baseline values in relapse patients.